Additional Aggressive Cancers Can Be Found Using Breast MRI Following Mammography Screening
By MedImaging International staff writers Posted on 25 Nov 2015 |
The results of a study published online in the journal Radiology have shown that performing MRI scans, after the discovery of mammography breast cancer findings, sometimes shows larger and more aggressive tumors than those discovered in mammography.
Breast Magnetic Resonance Imaging (MRI) is widely used for the screening of high-risk patients, and pre-surgical planning, and is the most sensitive imaging technique available for detecting breast cancer. In younger women, and those with dense breasts, MRI can detect cancers that have two or more distinct primary tumors, often in different breast quadrants. Most of the so-called multicentric cancers were discovered in women with heterogeneously dense or very dense breasts, but cancer was also found in 19% of patients with fatty or scattered fibro-glandular tissue.
The researchers reviewed the records of 2,021 patients that had newly-diagnosed breast cancer, had preoperative MRI, and a biopsy. The MRI detected additional cancers that were not found in the mammography, in 14% (285) of the patients. In 25.6% (73) of the 285 patients the MRI revealed one or more additional cancers in a different breast quadrant than the index cancer, or that detected by breast palpation and/or mammography. In 17 of the 73 patients (23.3%) the multicentric cancers were larger than the known index cancer. The MRI scan also detected multicentric cancers larger than 1 cm in 25% of the 73 patients.
Lead author of the study, Chiara Iacconi, MD, Breast Unit, USL1 Massa-Carrara, (Carrara, Italy), said, “Patients with clinically insignificant cancers undergoing potential overtreatment versus patients who may be undertreated is at the heart of the controversy surrounding breast MRI. We believe invasive cancer larger than 1 centimeter is clinically relevant disease. In general, it is accepted that radiation can likely treat invasive cancer less than 1 centimeter, but lesions larger than 1 centimeter, especially invasive carcinomas, may not be reliably treated with conservation. The results show that multicentric cancer detected on breast MRI after mammography appears to represent a larger tumor burden in approximately a quarter of patients and can result in potential changes to cancer grade and treatment.
Related Links:
USL1 Massa-Carrara
Breast Magnetic Resonance Imaging (MRI) is widely used for the screening of high-risk patients, and pre-surgical planning, and is the most sensitive imaging technique available for detecting breast cancer. In younger women, and those with dense breasts, MRI can detect cancers that have two or more distinct primary tumors, often in different breast quadrants. Most of the so-called multicentric cancers were discovered in women with heterogeneously dense or very dense breasts, but cancer was also found in 19% of patients with fatty or scattered fibro-glandular tissue.
The researchers reviewed the records of 2,021 patients that had newly-diagnosed breast cancer, had preoperative MRI, and a biopsy. The MRI detected additional cancers that were not found in the mammography, in 14% (285) of the patients. In 25.6% (73) of the 285 patients the MRI revealed one or more additional cancers in a different breast quadrant than the index cancer, or that detected by breast palpation and/or mammography. In 17 of the 73 patients (23.3%) the multicentric cancers were larger than the known index cancer. The MRI scan also detected multicentric cancers larger than 1 cm in 25% of the 73 patients.
Lead author of the study, Chiara Iacconi, MD, Breast Unit, USL1 Massa-Carrara, (Carrara, Italy), said, “Patients with clinically insignificant cancers undergoing potential overtreatment versus patients who may be undertreated is at the heart of the controversy surrounding breast MRI. We believe invasive cancer larger than 1 centimeter is clinically relevant disease. In general, it is accepted that radiation can likely treat invasive cancer less than 1 centimeter, but lesions larger than 1 centimeter, especially invasive carcinomas, may not be reliably treated with conservation. The results show that multicentric cancer detected on breast MRI after mammography appears to represent a larger tumor burden in approximately a quarter of patients and can result in potential changes to cancer grade and treatment.
Related Links:
USL1 Massa-Carrara
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer